George I. Papakostas, MD

Supplement Article

Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change

January 27, 2016

George I. Papakostas

Original Research

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

December 23, 2015

Maurizio Fava, George I. Papakostas, Richard C. Shelton, et al

Letter to the Editor

Reply to Commentary by Rothschild: "A Blood Test for Depression?"

August 26, 2015

George I. Papakostas, Richard C. Shelton, John A. Bilello, et al

Educational Activity

Antidepressants and Their Effect on Cognition in Major Depressive Disorder

August 26, 2015

George I. Papakostas

Educational Activity

Components of Cognitive Functioning and Their Measurement

June 24, 2015

George I. Papakostas

Academic Highlights

Managing Cognition in MDD

April 22, 2015

Patients with MDD may experience cognitive dysfunctions that make recovery difficult or incomplete. Read this new Academic Highlights to learn to understand and identify problems with cognition in depressed...

George I. Papakostas, Larry Culpepper

Original Research

MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder

February 25, 2015

George I. Papakostas, Richard C. Shelton, John A. Bilello, et al

Review Article

The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder

February 3, 2015

George I. Papakostas, Nadia Iovieno, SÃ¸ren D. Ã˜stergaard

ASCP Corner

Updates and Trends in the Treatment of Major Depressive Disorder

December 24, 2014

George I. Papakostas, Dawn F. Ionescu

Academic Highlights

Overview of Vortioxetine (Brintellix)

December 24, 2014

Understand what is Vortioxetine (Brintellix), an antidepressant for major depressive disorder and treatment-resistant depression.

Alan F. Schatzberg, Michael E. Thase, George I. Papakostas, et al

Letter to the Editor

Dr Mischoulon and Colleagues Reply

November 24, 2014

David Mischoulon, Maurizio Fava, George I. Papakostas, et al

Original Research

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

April 15, 2014

Maurizio Fava, George I. Papakostas, Richard C. Shelton, et al

Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

Reply to Commentary by Rothschild: "A Blood Test for Depression?"

Antidepressants and Their Effect on Cognition in Major Depressive Disorder

Components of Cognitive Functioning and Their Measurement

Managing Cognition in MDD

MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder

The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder

Updates and Trends in the Treatment of Major Depressive Disorder

Overview of Vortioxetine (Brintellix)

Dr Mischoulon and Colleagues Reply

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

ELSEWHERE:

FOLLOW US:

George I. Papakostas, MD

Identifying Patients With Depression Who Require a Change in Treatment and Implementing That Change

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

Reply to Commentary by Rothschild: "A Blood Test for Depression?"

Antidepressants and Their Effect on Cognition in Major Depressive Disorder

Components of Cognitive Functioning and Their Measurement

Managing Cognition in MDD

MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder

The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder

Updates and Trends in the Treatment of Major Depressive Disorder

Overview of Vortioxetine (Brintellix)

Dr Mischoulon and Colleagues Reply

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles